The spring home-selling season is shaping up to be a challenging one for major homebuilders amid a trade war and rising ...

Equities researchers at Wedbush lifted their Q4 2025 earnings per share estimates for shares of CarMax in a research note ...

Research analysts at Wedbush issued their FY2029 EPS estimates for shares of Arcus Biosciences in a note issued to investors ...

Analyst Dan Ives thinks Tesla stock could soar from current levels thanks to a potential $1 trillion catalyst.

Avalo Therapeutics (AVTX) stock surges as Wedbush initiates with a bullish view, citing lead asset AVTX-009's potential against hidradenitis suppurativa. Read more here.

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.

Shares of Rivian Automotive slipped after the company said it expects to deliver fewer vehicles in 2025 than it did last year against an uncertain backdrop for EV demand. The stock was down 3.8% at ...

Carvana said in its guidance it expects “significant growth” in both retail units sold and adjusted EBITDA for full-year 2025 ...

Dan Ives, Wedbush Securities global head of technology research and senior equity analyst, joins 'Squawk Box' to discuss ...

Tesla (TSLA) stock has jumped 83% over the past year. However, the EV (electric vehicle) maker’s stock has retreated about 17 ...